Brief: Samsung Biologics To Acquire Polypeptide Group AG For 2.7 Trln Won
19/07/2026 23:58
BRIEF-Samsung Biologics To Acquire Polypeptide Group AG For 2.7 Trln Won July 20 (Reuters) - Samsung Biologics Co Ltd 207940.KS:
SAMSUNG BIOLOGICS TO ACQUIRE POLYPEPTIDE GROUP AG FOR 2.7 TRLN WON
Further company coverage: 207940.KS
((Heekyong.Yang@thomsonreuters.com;))
Recent news on PolyPeptide AG
See all newsBrief: Polypeptide Group Definitive Interim Result Of The Public Tender Offer Of Samsung Biologics
Brief: Polypeptide Group Provisional Interim Result Of The Public Tender Offer Of Samsung Biologics Co
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Samsung Biologics to launch takeover bid for PolyPeptide in September (updated)